IMDZ - Immune Design Corp.
| Previous Close | 3.65 |
| Open | 3.60 |
| Bid | 3.50 x 1500 |
| Ask | 3.85 x 1000 |
| Day's Range | 3.45 - 3.75 |
| 52 Week Range | 2.80 - 13.05 |
| Volume | 195,162 |
| Avg. Volume | 461,411 |
| Market Cap | 168.438M |
| Beta | 2.15 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.75 |
| Earnings Date | May 15, 2018 - May 21, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.00 |
- Zacks•9 days ago
Why Is Immune Design (IMDZ) Down 2.7% Since Its Last Earnings Report?
Immune Design (IMDZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- GlobeNewswire•20 days ago
Report: Developing Opportunities within VAREX IMAGING, Movado Group, Equity Bancshares, Huntington Ingalls Industries, Immune Design, and Westwood Holdings Group — Future Expectations, Projections Moving into 2018
NEW YORK, April 02, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- Simply Wall St.•last month
Immune Design Corp (NASDAQ:IMDZ): Earnings To Drop Next Year, Is It A Long-Term Trend?
The most recent earnings update Immune Design Corp’s (NASDAQ:IMDZ) released in December 2017 signalled that losses became smaller relative to the prrior year’s level – great news for investors Below,Read More...
- Zacks•last month
Immune Design Poised on Progress of Pipeline Candidates
Development of key pipeline candidates CMB305 and G100 is likely to keep Immune Design (IMDZ) on a growth trajectory.
- Zacks•last month
Immune Design (IMDZ) Posts Narrower-Than-Expected Loss in Q4
Immune Design (IMDZ) reports narrower-than-expected loss in fourth quarter 2017 results and updates data for its pipeline candidates.
- Thomson Reuters StreetEvents•last month
Edited Transcript of IMDZ earnings conference call or presentation 14-Mar-18 8:30pm GMT
Q4 2017 Immune Design Corp Earnings Call
- Associated Press•last month
Immune Design reports 4Q loss
The Seattle-based company said it had a loss of 29 cents per share. The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a ...
- GlobeNewswire•last month
Immune Design Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
-New positive clinical and translational data for both lead agents. -Strong balance sheet with 2017 year-end cash and equivalents of $144.2 Million. -Conference call at 1:30 pm Pacific today.
- Simply Wall St.•last month
Interested In Immune Design Corp (NASDAQ:IMDZ)? Here’s How It Performed Recently
Assessing Immune Design Corp’s (NASDAQ:IMDZ) past track record of performance is a valuable exercise for investors. It enables us to reflect on whether the company has met or exceed expectations,Read More...
- GlobeNewswire•last month
Immune Design Reports Data Update for Lead Immunotherapy Programs: Improvement in Survival for CMB305 Monotherapy in Sarcoma and Increased Objective Responses for G100/pembrolizumab Combination in Follicular Lymphoma
Median overall survival of 23.7 months following CMB305 monotherapy represents approximately one-year extension of survival compared to published data in soft tissue sarcoma patient population Objective ...
- GlobeNewswire•2 months ago
Immune Design to Report Fourth Quarter and Year End 2017 Financial Results and Provide Corporate Update
SEATTLE and SOUTH SAN FRANCISCO, Calif., March 07, 2018-- Immune Design, an immunotherapy company focused on next-generation therapies in oncology, today announced that it will report fourth quarter and ...
- Zacks•2 months ago
What's in the Cards for Immune Design (IMDZ) in Q4 Earnings?
We expect Immune Design (IMDZ) to shed light on the progression of the trails on pipeline candidates when it releases fourth-quarter earnings results on Mar 6.
- Simply Wall St.•2 months ago
Best Growth Stock Picks
Immune Design and Westlake Chemical Partners are a few noticeable companies with a strong future outlook. The market’s optimistic sentiment towards these stocks indicates a level of confidence in theRead More...
- GlobeNewswire•2 months ago
Immune Design to Present at Upcoming Investor Conferences
SEATTLE and SOUTH SAN FRANCISCO, Calif., Feb. 09, 2018-- Immune Design, an immunotherapy company focused on next-generation therapies in oncology, today announced that senior management will present at ...
- GlobeNewswire•3 months ago
Consolidated Research: 2018 Summary Expectations for Immune Design, Primoris Services, Scotts Miracle-Gro, Heska, Calyxt, and Urstadt Biddle Properties — Fundamental Analysis, Key Performance Indications
NEW YORK, Jan. 30, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Immune ...
- Zacks•4 months ago
Why Immune Design (IMDZ) Could Beat Earnings Estimates Again
Immune Design (IMDZ) boasts a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
- Capital Cube•4 months ago
ETFs with exposure to Immune Design Corp. : December 25, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Immune Design Corp. Here are 5 ETFs with the largest exposure to IMDZ-US. Comparing the performance and risk of Immune Design Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
- Zacks•4 months ago
Options Traders Expect Huge Moves in Immune Design (IMDZ) Stock
Immune Design (IMDZ) needs investors to pay close attention to the stock based on moves in the options market lately.
- Zacks•5 months ago
Options Traders Expect Huge Moves in Immune Design (IMDZ) Stock
Investors in Immune Design (IMDZ) need to pay close attention to the stock based on moves in the options market lately.
- Capital Cube•5 months ago
ETFs with exposure to Immune Design Corp. : November 13, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Immune Design Corp. Here are 5 ETFs with the largest exposure to IMDZ-US. Comparing the performance and risk of Immune Design Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
